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Background: Loeys–Dietz syndrome, also known as Marfan syndrome type II, is a rare connective tissue disorder
caused by dominant mutations in transforming growth factor-beta receptors (TGFBR1 and 2).
Case presentation: We report a 7-year-old Japanese boy with Loeys–Dietz syndrome who carried a novel, de novo
missense mutation in TGFBR2 (c.1142g > c, R381P). He showed dysmorphic faces and skeletal malformations that
were typical in previous cases with Loeys-Dietz syndrome. The cardiac studies disclosed the presence of markedly
dilated aortic root and patent ductus aorteriosus. The cranial magnetic resonance imaging (MRI) and angiography
(MRA) detected the tortuous appearances of the bilateral middle cerebral and carotid arteries.
Conclusion: This study depicts the systemic vascular phenotypes of a child with Loeys–Dietz syndrome that
were caused by a novel heterozygous mutation of TGFR2. A large cohort with serial imaging studies for vascular
phenotypes will be useful for delineating the genotype-phenotype correlations of Loeys–Dietz syndrome.
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Magnetic resonance imaging (MRI)Background
Loeys–Dietz syndrome is a rare congenital disorder
characterized by loose connective tissue [1,2]. As a variant
form of Marfan syndrome, affected individuals exhibit
progressive vascular diseases such as dilation of the aortic
root, aortic dissection and valvular insufficiency [1-3].
In addition to these common phenotypes, patients with
Loeys–Dietz syndrome manifest distinct anomalies, such
as ocular hypertelorism, high-arched palate, bifid uvula,
scoliosis and clubfoot [1,2].
Vascular complications in Loeys–Dietz syndrome are
known to progress more rapidly than those in Marfan
syndrome [2,3]. Hence the precise diagnosis of Loeys–Dietz
syndrome is a critical issue in the long-term management
of affected individuals. In this report, we present a Japanese
boy with Loeys–Dietz syndrome who carried a novel* Correspondence: ysakai22q13@gmail.com
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reproduction in any medium, provided the ormutation in the TGFBR2 gene. This study highlights
the moderate to severe vascular phenotypes that resulted
from an R381P mutation in TGFBR2.Methods
MR imaging was performed using a 3.0T system (Intera
Achieva; Philips Medical Systems, Best, Netherlands).
Polymerase chain reaction (PCR) amplifying the coding
exons of TGFBR2 (chr3:30647994–30735633) was per-
formed as previously described [1,2,4]. Sequencing reac-
tions were performed with the BigDyeW Terminator v3.1
cycle sequencing kit (Life Technologies, Grand Island, NY,
U.S.A.) according to the manufacturer’s protocol.Case Presentation
A 7-year-old Japanese boy born to healthy Japanese parents
was referred to our department for assessment of systemic
anomalies. He had undergone surgical repairs for right
undescended testis, inguinal hernia and right clubfoot.
Genetic disorders were suspected from his dysmorphicd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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hair formation on the right lower mandible, and bifid
uvula (Figure 1A-C). Physical examination also revealed
hypermobility of joints (not shown), talipes equino-
varus and scoliosis (Figure 1D-F). His intelligence was
normal. He had no history of stroke, heart attack or
arrhythmia. Ocular examination excluded ectopia lentis.
Ehlers-Danlos syndrome or related connective disorders
were suspected from these clinical features. Computed
tomography (CT) scan revealed protrusion of the aortic
arch (Figure 2A) and the presence of a patent ductus
arteriosus (Figure 2B). Echocardiography revealed aortic
root dilatation to 26.7 mm in diameter (Figure 2C). The
dysmorphic features and cardio-vasuclar phenotypes of
the present case allowed us to diagnose him as having
Loeys–Dietz syndrome. To confirm the genetic diagnosis
of Loeys–Dietz syndrome, we sequenced the coding exons
of the TGFBR2 gene. A novel heterozygous missense
mutation (c.1142g > c, R381P) was detected in TGFBR2
exon 5 of the proband (Figure 3A) but not his parents
(Figure 3B).
To assess systemic vascular malformation, we performed
cranial and cervical magnetic resonance imaging (MRI)
studies. The MR angiographies revealed the prominently
tortuous appearance of the vertebral, carotid and middle
cerebral arteries (Figure 4A and B). These findings were
consistent with those in previous reports [5,6]. NoFigure 1 Dysmorphic features of the present case. The patient shows t
hypertelorism and mild strabismus (A). Other symptoms include ectopic ha
uvula (C), bilateral clubfoot (D), and kyphoscoliosis (E, F).vascular aneurysm was identified in the cervical and
cranial MRI. Of note, we found in the cranial MRI that
unusually enlarged perivascular spaces at the bilateral
posterior white matter without ischemic damage, hemor-
rhagic lesions or metabolic degeneration (Figure 5A-C).
Spinal MRI detected enlarged sacral foramina as typically
observed in Marfan syndrome and Loeys–Dietz syndrome
(data not shown).
Conclusions
This report presents the systemic phenotypes of Loeys–
Dietz syndrome that were caused by a novel TGFBR2
mutation (R381P) in a Japanese case. The systemic
vascular phenotypes of this case indicate the strong
penetrance as well as the dominant effects of the het-
erozygous missense mutation.
The TGFBR2 gene encodes transforming growth factor-
beta receptor II (70/80 kDa), a membrane-bound, serine/
threonine kinase domain-containing protein. This protein
forms a heterodimeric complex with another receptor
protein, thereby activating the downstream signaling
molecules, such as SMAD proteins, upon stimulation
by TGF-beta ligands. Previous studies showed that the
majority of pathogenic TGFBR2 mutations were identified
in the exons encoding the protein kinase domain [1-3].
In vitro studies suggested that such mutations disturbed
not only the kinase activity of TGFBR2, but alsohe typical facial appearance for Loeys-Dietz syndrome with ocular
ir growth on the right mandible (B), high-arched cleft palate with bifid
Figure 2 Cardiovascular phenotypes of the present case. Imaging studies from a 3D-reconstructed CT scan (A) and echocardiographies
(B and C) are shown. The case had abnormally dilated the aortic root (A, B) and the patent ductus arteriosus (arrows in A and C). Note that, in
panel C, the shunt flows are present across the ductus.
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dominant effects of heterozygous mutations. Given that
the R381P mutation in this case (Figure 3A) was also
located at the kinase domain of TGFBR2, we speculated
that the mutation caused deleterious effects on both
its kinase activity and the receptor internalization. An
angiotensin II receptor antagonist, losartan, has been
recently shown to down-regulate the expression of
TGFBRs, and thus proved to be effective in preventing
the progressive aortic dilation and development of
aneurysm in Marfan and Loeys-Dietz syndromes. A
large cohort, including the present case, is thus
needed to monitor its efficacy and side effects, therebyFigure 3 The de novo mutation at TGFBR2 exon 5. The sequence chrom
the proband’s DNA (A). The arrow indicates the position of the missense m
(B) show the normal TGFBR2 genotype (left, father; right, mother).elucidating prognostic factors and contraindications of
the therapies.
It is well known that prevention of aortic dilation is a
vital issue for the long-term survival of patients with
Loeys-Dietz syndrome. On the other hand, there are no
reports clearly demonstrating the association of Marfan
or Loeys-Dietz syndrome with neurovascular complications
[7,8]. Nonetheless, recent reports showed sporadic cases
with intracranial aneurysm as well as tortuosity of carotid
arteries in this disorder [7,9,10]. Given the progressive
nature of the cardiovascular phenotypes of Loeys–Dietz
syndrome, one could argue that only severely affected
cases may experience such late-onset neurovascular com-atograms show the heterozygous mutation in TGFBR2 (c.1142g > c) in
utation replacing Arg381 (cgg) with Pro (ccg). The parents of the case
Figure 4 Neurovascular phenotypes in magnetic resonance imaging. The cranial and cervical magnetic resonance angiography displays the
tortuous appearances of the carotid, middle cerebral (A) and vertebral arteries (B).
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enlarged perivascular lumens in this case (Figure 5A-C)
are associated with the neurovascular phenotypes of
Loeys-Dietz syndrome. Future studies will address the
issues of their genotype-phenotype correlations, particu-
larly on their comorbidity with neurovascular complica-
tions. Large cohorts with serial imaging studies can beFigure 5 Enlarged Virchow–Robin spaces in the present case. The sag
weighted images (D) show the dilated perivascular “Virchow–Robin” spaces (a
the fluidal spaces in the lateral ventricle (A-D). Diffusion-weighted images we
presence of subarachnoid cyst at the right middle cranial fossa.considered to determine whether certain genotypes may
correlate to their specific phenotypes.
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